Navigation Links
When Your Breakfast is Considered a 'Drug'
Date:5/21/2009

CHICAGO, May 21 /PRNewswire/ -- Millennium Medical Information Services, Inc. reports that the Food and Drug Administration (FDA) recently issued a Warning Letter to General Mills for illegally marketing their new "drug," commonly known as Cheerios(R) Toasted Whole Grain Oat Cereal (Cheerios(R)). The FDA Warning Letter serves as a healthy reminder as to the unintended consequences that may arise when navigating the comprehensive regulatory scheme governing the marketing and promotion of food and drugs in the United States. The FDA Warning Letter gives rise to the fundamental question: Are Cheerios(R) a food or a drug?

The Cheerios(R) box reviewed by the FDA included the following statements:

  • "you can Lower Your Cholesterol 4% in 6 weeks"
  • "Did you know that in just 6 weeks Cheerios can reduce bad cholesterol by an average of 4 percent? Cheerios is. . . clinically proven to lower cholesterol. A clinical study showed that eating two 1 1/2 cup servings daily of Cheerios cereal reduced bad cholesterol when eaten as part of a diet low in saturated fat and cholesterol."

According to the Federal Food, Drug, and Cosmetic Act, a "drug" includes "articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals. . ." 21 U.S.C. section 321(g)(1)(B). Based on the claims set forth on the Cheerios(R) label, the FDA opined "that Cheerios(R) is intended for use in lowering cholesterol, and therefore in preventing, mitigating, and treating the disease hypercholesterolemia. Additionally, the claims indicate that Cheerios(R) is intended for use in the treatment, mitigation, and prevention of coronary heart disease through, lowering total and "bad" (LDL) cholesterol." General Mills, Inc., Warning Letter, http://www.fda.gov/foi/warning_letters/s7188c.htm, accessed May 13, 2009.

Since Cheerios(R) "is not generally recognized, among experts . . .as safe and effective for use . . . suggested in the labeling . . ." it qualifies as a "new drug" under the Act. 21 U.S.C. section 321(P)(1). Unfortunately for General Mills, the Act requires agency approval of a new drug application prior to the introduction of a "new drug" into interstate commerce. 21 U.S.C. section 355(a).

When a drug is also food

Although the FDA clearly views Cheerios(R) as a "drug" by virtue of its intended use as described on the label, the Agency also analyzed the product claims pursuant to the regulatory authority governing health claims in food substances. Specifically, the agency refers to the permissible soluble fiber health claim and the requirements set forth in the applicable regulations. The FDA determined that General Foods failed to conform to the specific requirements of the soluble fiber health claim to the extent that they attributed a degree of risk reduction (4% in 6 weeks) for coronary heart disease to diets that include foods eligible to bear the claim.

In addition, the FDA found that General Foods misbranded Cheerios(R) by including unauthorized health claims in its labeling. The claim referenced by the FDA was as follows: "Heart-healthy diets rich in whole grain foods, can reduce the risk of heart disease." http://www.fda.gov/foi/warning_letters/s7188c.htm, page 3, accessed May 13, 2009).

Interestingly, the claim referenced above did not appear on the Cheerios(R) box, but rather appeared on a General Mills website located at www.wholegrainnation.com. According to the Act, "[t]he term 'labeling' means all labels and other written, printed, or graphic matter (1) upon any article or any of its containers or wrappers, or (2) accompanying such article. Because the above-referenced claim appeared on a website, the address for which was located on the Cheerios(R) box, the FDA considered the content on the website as part of the product labeling.

Historically, the FDA and Federal courts have taken an expansive view of what is included in a product's labeling. The term "labeling" has been broadly interpreted and is not restricted to information that accompanies the product. In fact, "labeling" has been broadly defined to include any literature that "supplements or explains" a drug, including "advertising or descriptive matter"-"[n]o physical attachment one to the other is necessary." See, Kordel v. United States, 335 U.S. 345, 348-50, 69 S.Ct. 106, 93 L.Ed. 52 (1948) (affirming broad definition of "Labeling" under the Food, Drug, and Cosmetic Act). For example, the FDA has taken the position that the mailing of a re-print of a scientific journal article constitutes product "labeling" to the extent the article makes a claim about the manufacturer's product. FDA, Letter of T. E. Byers to Sterling Drug Co. regarding distribution of medical journal reprint to 80,000 physicians, Regulatory Letter 78-HFD-312-6 (Nov. 21, 1978). See also, U.S. v. Articles of Drug Consisting of Following: 5,906 Boxes, 745 F.2d 105, 39 Fed. R. Serv. 2d 1481 (1st Cir. 1984) (Index cards delivered to physicians); FDA Reg Ltr 80-PHI-03, to Y. L. Johnson, Clifton Pharmacal (Nov. 1979) (Flyers delivered to pharmacists); Dickinson, Oraflex--No Wrongdoing?, 7 Pharmaceutical Technology 23 (Feb. 1983) (Press kit materials for briefings to journalists).

Conclusions

The FDA Warning Letter to General Mills serves as a reminder of the expansive definition of a "drug" under the Act and the unintended consequences which may occur from seemingly innocuous product claims. In addition, the Warning Letter serves as a reminder with regard to the expansive nature of product "labeling" under the Act. When formulating marketing pieces that include product/drug claims, marketers and their agents should consider the broad definition of "labeling" under the Act and the ramifications of a misbranding claim.

If you would like to continue to receive periodic updates on regulatory developments from the FDA and State and Federal authorities, please email us at info@millennium-mis.com to subscribe to the Millennium Medical Information Services, Inc. Regulatory Newsletter.


'/>"/>
SOURCE Millennium Medical Information Services, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Right breakfast bread keeps blood sugar in check all day
2. Sunday, October 14, MSPP holds Sixth Annual Lucero Memorial Run and Latino Leadership Breakfast
3. got breakfast?(TM) Foundation Issues Statement on Recently Released Florida State Plan of Action from the Governors Council on Physical Fitness
4. Breakfast BREAKS and Teen Music Phenomenon the Jonas Brothers Team Up to Raise Awareness about the Importance of Eating Breakfast
5. Skip Breakfast, Pack on the Pounds
6. Help Your Kids Earn an A for Attentiveness with a Bowl of Frosted Mini- Wheats(R) Cereal for Breakfast
7. Sierra Tucson Recognizes Professionals at Gratitude for Giving Breakfast
8. Big, Well-Balanced Breakfast Aids Weight Loss
9. Natural Harmony Foods Breakfasts to be National in Tree of Life
10. Breakfast Eggs Keep Folks on Diet
11. Preparing To Send Your Children Off To School? Healthy Breakfast, Lunch and Snack Ideas From Cabot(R) Can Contribute to a Better, More Productive School Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations ... literacy software tool, and the Cancer Patient Education Network (CPEN), an independent professional ... announce a new strategic alliance. , As CPEN’s strategic partner, HLI will ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/22/2017)... , Sept. 22, 2017 AVACEN Medical (AVACEN) ... is now successfully helping those with the widespread pain ... Fibromyalgia diagnosed Amanda in Essex, England ... washing my hair, experiencing no sleep at all, tremendous ... spasm… I cannot recommend [the AVACEN 100] enough, how ...
Breaking Medicine Technology: